Stack of newspapers on a computer keyboard.

In the News

Contract Pharma (June 2024)

Breaking barriers: Strategic use of FSP models to expand trials into non-footprint countries

Lisa Beckel discusses how leveraging functional service provider models can enhance global clinical trial reach and inclusion.

Contract Pharma
BioSpectrum Asia (May 2024)

From Hematologic to Autoimmune Disease – The CAR-T Therapy Second Revolution

CAR-T therapy has entered a new era with its potential application in autoimmune, metabolic and other chronic conditions. Davide Garrisi and Kim Watanabe explore how CAR-T therapy is poised to make a significant impact on patients' lives.

BioSpectrum Asia logo
Drug Discovery & Development (May 2024)

Five critical elements for maximizing functional service partnerships

As organizations look more to functional service partnership models to outsource specific functions of clinical trials, the authors discuss five keys to successfully implementing those relationships.

Drug Discovery & Development Logo
Pharmaceutical Outsourcing (May 2024)

Beat the clock: How an FSP model can optimize a follow-the-sun approach in clinical development functions

Our experts discuss how a follow-the-sun model delivered in a flexible functional service provider outsourcing model is being used to respond to more challenging timelines.

pharmaceutical outsourcing logo
Drug Discovery & Development (May 2024)

How much does a clinical research associate impact a company’s carbon footprint? More than you might think!

Michael Cohen discusses the need to better understand our respective carbon footprints and develop solutions to reduce the environmental impact of clinical trials.

Drug Discovery & Development Logo
BioSpectrum Asia (April 2024)

What’s APAC’s recipe of success in clinical trials market?

Ding Ming talks about the ongoing efforts foster an environment that is more conducive to clinical trials.

BioSpectrum Asia logo
Drug Discovery & Development (April 2024)

Real-world evidence key to navigating new policy changes

Evidera’s Ariel Berger and Almudena Olid Gonzalez discuss the expanding role of real-world evidence in drug development.

Drug Discovery & Development Logo
Applied Clinical Trials (April 2024)

Unleashing their potential: the evolving landscape of DHTs

Jill Sommerville, Lauren Flood and Matthew Ryan outline key considerations in deploying fit-for-purpose digital health technologies in drug development.

AppliedClinTrials logo
CenterWatch Monthly (April 2024)

Cracking the talent shortfall: strategies for delivering the right talent with an FSP model

Jason Tate lays out multiple approaches to weathering clinical research workforce constraints through the use of FSPs.

CenterWatch Logo